- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03490409
Effect of Compression Therapy on Postoperative Swelling and Pain After Total Knee Arthroplasty
Effect of Compression Therapy on Postoperative Swelling and Pain, Among Patients With a BMI ≥30 kg/m2, After Total Knee Arthroplasty: A Randomized Controlled Pilot Study
The number of severely obese patients who has knee replacement surgery is rising. Obesity increases the risk of the postoperative swelling. A complication which can cause pain and discomfort as well as complicate and prolong rehabilitation.
The aim of the present pilot study is to examine the effect of a compression stocking on postoperative swelling and pain among patients with a BMI ≥30 kg/m2, after total knee arthroplasty. The hypothesis is that the use of a medical elastic compression stocking for 14 days postoperatively may reduce postoperative swelling by two cm.
The pilot study will furthermore provide useful information for feasibility which will be used to decide whether or not a larger study should be initiated.
Study Overview
Detailed Description
In Denmark approximately 9000 knee replacements were performed in 2015. Almost 7000 of the procedures performed were total knee arthroplasties.
A total knee arthroplasty is a common procedure performed as treatment for knee arthritis.
In 2015, 39,9% of the patients in Denmark who had knee replacement surgery were severely obese with a BMI ≥30 kg/m2.
The percentage of severely obese patients who has knee replacement surgery is rising and studies have shown that obesity increases the risk of postoperative complications.
A danish cross-sectional study found that swelling with a prevalence of 90,7% was the most frequent patient-reported complication after knee arthroplasty. A common postoperative complication after total knee arthroplasty and severe obesity increases the risk of postoperative swelling.
Postoperative swelling may impair movement of the knee, cause pain and discomfort as well as complicate and prolong rehabilitation.
Despite that a BMI 30 kg/m2 causes more postoperative complications, obese patients experience the same quality of life and improvement of function after total knee arthroplasty as patients with a BMI ≤30 kg/m2. The higher complication rate among the obese patients has socioeconomic consequences due to readmission and unscheduled outpatient visits.
A study found that in the first 30 days postoperative after total knee arthroplasty 2,9 percent of the patients were readmitted. In 2015 7,3% of the patients who had primary knee replacement surgery in Denmark were readmitted within 30 days after the operation. Unscheduled outpatient visits 30 days post-surgery, is related to swelling in the operated leg. There is a need for further research on interventions that may prevent postoperative swelling after knee replacement surgery. A compression stocking is a feasible intervention and an effective treatment in the prevention of swelling. The stocking provides measured pressure against the leg which helps the blood to move up toward the heart. By improving the blood flow, swelling is prevented and reduced.
A Danish randomized controlled study (RCT), that investigated the effect of a compression stocking when used for four weeks postoperatively found that the stocking did not have a clinical effect on postoperative swelling.
However the stocking was the day after the surgery, where seventy percent of the postoperative swelling already had occurred.
Therefore it is relevant to investigate whether a compression stocking has an effect on postoperative swelling, when applied immediately after the operation has ended.
The aim of the present pilot study is to examine the effect of a compression stocking on postoperative swelling and pain among patients with a BMI ≥30 kg/m2, after total knee arthroplasty. The aim of the pilot study is furthermore to provide useful information for feasibility which will be used to decide whether or not a larger RCT should be initiated.
All patients will be recruited at Department for planned Orthopaedic Surgery, Naestved Hospital, Denmark.
Inclusion criteria: planned for total knee arthroplasty, BMI ≥30 kg/m2, aged 18 or older, speaks, reads and understands danish and written informed consent.
Collaborating researchers and departments :
Department for Planned Orthopaedic Surgery, Ringstedgade 61, Naestved Hospital, Denmark.
Odense Patient data Explorative Network, J.B. Winsloew Vej 9a, 3. Sal, 5000 Odense C, Denmark
44 patients will be included in the pilot study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Naestved, Denmark, 4700
- Department for planned Orthopaedic Surgery
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Planned for total knee arthroplasty
- BMI ≥30 kg/m2, aged 18 or older
- Speaks, reads and understands Danish
- Written informed consent.
Exclusion Criteria:
- Peripheral Arterial Disease
- Arterial insufficiency
- No palpable puls at the arteria dorsalis pedis
- Severe atherosclerosis
- Leg ulcers
- Skin disease
- Fragile "tissue paper" skin
- Neuropathy or other cause of sensory impairment
- Allergy to the stocking material
- Massive leg edema or pulmonary edema from congestive cardiac failure,
- Deformity of the leg or unusual leg shape or size preventing correct fit
- Patient that cannot cooperate. For example does not understand the concept of Visual Analogue Scale (VAS) or is not able to use the compression stocking
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: compression stocking
The intervention group will receive a thigh compression stocking, which is to be used for 24 hours a day for 14 days after surgery.
|
Thigh compression stocking
|
No Intervention: Conventional treatment
The control group will receive conventional treatment, a compression bandage placed at the end of surgery and removed on the night of the surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Swelling of the knee after operation
Time Frame: Assessment of swelling of the knee from baseline and 1, 2, 14 days after surgery
|
Measurements will be taken on the day of admission before surgery and at day 1, 2 and 14 days after surgery in millimeters to determine whether swelling has occurred.
No predetermined higher or lower values.
Higher values represent a worse outcome.
Lower values represents a better outcome.
|
Assessment of swelling of the knee from baseline and 1, 2, 14 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Swelling of the calf after the operation.
Time Frame: Assessment of swelling of the calf from baseline and 1, 2, 14 days after surgery
|
Measurements will be taken on the day of admission before surgery and at day 1, 2 and 14 days after surgery in millimeters to determine whether swelling has occurred.
No predetermined higher or lower values.
Higher values represent a worse outcome.
Lower values represents a better outcome.
|
Assessment of swelling of the calf from baseline and 1, 2, 14 days after surgery
|
Swelling of the ankle after the operation.
Time Frame: Assessment of the swelling of the ankle from baseline and 1, 2, 14 days after surgery
|
Measurements will be taken on the day of admission before surgery and at day 1, 2 and 14 days after surgery in millimeters to determine whether swelling has occurred.
No predetermined higher or lower values.
Higher values represent a worse outcome.
Lower values represents a better outcome.
|
Assessment of the swelling of the ankle from baseline and 1, 2, 14 days after surgery
|
Pain after the operation.
Time Frame: Assessment of pain from baseline and 1, 2, 14 days after surgery
|
Measurements will be taken on the day of admission before surgery and at day 1, 2 and 14 days after surgery using Visual Analogue Scale.
A pain measurement scale.
Minimum score is 0 and maximum score is 100.
Higher values represent a worse outcome.
Lower values represents a better outcome.
|
Assessment of pain from baseline and 1, 2, 14 days after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Linda Mie Christensen, nurse, Naestved Sygehus
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SJ-635
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Edema
-
Eye-yon MedicalCompletedCORNEAL EDEMAIsrael, Poland
-
Federico II UniversityCompletedPseudophakic Cystoid Macular Edema
-
California Retina ConsultantsRegeneron PharmaceuticalsCompletedDiabetic Macular Edema | Cystoid Macular EdemaUnited States
-
Postgraduate Institute of Medical Education and...CompletedDiabetic Macular Edema | Vision Disorders | Macular Edema, Cystoid | Clinically Significant Macular EdemaIndia
-
National Cardiovascular Center Harapan Kita Hospital...CompletedMyocardial Edema
-
OcugenNot yet recruitingDiabetic Macular Edema | Center Involved Diabetic Macular Edema
-
Eye-yon MedicalCompletedChronic Cornel EdemaNetherlands, Israel, Germany, Spain
-
University of RochesterNeuroMetrix, Inc.Active, not recruiting
-
Luca MarinEnrolling by invitation
Clinical Trials on Thigh compression stocking
-
Laboratoires InnotheraBiotrialCompleted
-
University Hospitals Cleveland Medical CenterWithdrawn
-
Imperial College LondonUniversity College, London; University of Edinburgh; University of Manchester; Universidad...TerminatedDeep Vein Thrombosis | Post Thrombotic Syndrome | Deep Vein Thrombosis LegUnited Kingdom
-
Khoo Teck Puat HospitalCompletedObstructive Sleep ApneaSingapore
-
Herlev and Gentofte HospitalCompleted
-
Qassim UniversityCompletedChronic Venous InsufficiencySaudi Arabia
-
University of HaifaCompletedHealthy Runners. Compression Stocking and PerformanceIsrael
-
Sir Mortimer B. Davis - Jewish General HospitalCanadian Institutes of Health Research (CIHR); Sigvaris CorporationCompletedDeep Venous ThrombosisUnited States, Canada
-
BSN Medical IncUnknownChronic Venous DiseaseUnited States
-
Pirogov Russian National Research Medical UniversityRecruitingVaricose Veins | Chronic Venous InsufficiencyRussian Federation